Key result
A tunneled technique for subpericardial placement of a 4.2 Fr Broviac catheter potentially eliminates the need for postoperative percutaneous central venous lines in neonates.
Why the study?
Does a tunneled subpericardial Broviac catheter technique improve safety and reduce thrombogenicity in neonates undergoing congenital heart surgery?
Does a tunneled subpericardial Broviac catheter technique improve safety and reduce thrombogenicity in neonates undergoing congenital heart surgery?
Answers are grounded in this paper and cite their sources.
A novel tunneled subpericardial Broviac catheter technique may offer a safer, less thrombogenic medium-term venous access alternative for neonates undergoing congenital heart surgery.
We describe a strategy aimed at maximizing the safety and minimizing the thrombogenicity of central venous lines for neonates with congenital heart defects. Our method involves the use of a tunneled technique to place a 4.2 Fr single-lumen (Broviac) catheter in the subpericardial space, with minimal intravascular course and a tip placed in the lower right atrium. Using this technique, we potentially eliminated the requirement for percutaneous placement of central venous lines postoperatively as well as potentially decreased the risk of intrapericardial bleeding associated with transthoracic lines.
No takes yet. Share an insight, caveat, or question.
Raees et al. (2018) studied Congenital heart defects. Tunneled technique for subpericardial placement of a 4.2 Fr Broviac catheter was evaluated on Requirement for percutaneous placement of central venous lines postoperatively and risk of intrapericardial bleeding. A tunneled technique for subpericardial placement of a 4.2 Fr Broviac catheter potentially eliminates the need for postoperative percutaneous central venous lines in neonates.
Synapse has enriched 10 related papers. Consider them for comparative context: